Please use this identifier to cite or link to this item: https://www.arca.fiocruz.br/handle/icict/10532
Title: Perceptions of Human Tuberculosis Vaccine: The Fiocruz Latest Contribution
Authors: Antas, Paulo R. Z.
Affilliation: Fundação Oswaldo Cruz. Instituto Oswaldo Cruz. Laboratório de Imunologia Clínica. Rio de Janeiro, RJ, Brasil.
Abstract: As globally reported, tuberculosis (TB) is a major cause of illness and death worldwide, with increased burden mainly in developing countries. The Stop TB Partnership goals embrace dropping the global TB burden by half in 2015 and eliminating TB as a public health problem by 2050. As an ancient microbe highly adapted to the host, Mycobacterium tuberculosis infects humans through an oral route. TB can be caught by persons that inhale droplets containing the bacteria when an infected person coughs or sneezes. But the majority of these infected subjects will remain asymptomatic. In fact, this huge reservoir is blamed for the TB burden mainly in developing countries, causing the global resurgence of TB, which is further fueled by the HIV pandemic and the rise of M. tuberculosis multi (MDR)-, extremely (XDR)-, and totally (TDR)-drug resistant strains.....
Keywords: Tuberculosis
Vaccine
Fiocruz Latest Contribution
keywords: Fiocruz
Tuberculose
Vacinas
DeCS: Tuberculose
Vacina
Issue Date: 2014
Publisher: Jacobs Publishers
Citation: ANTAS, Paulo R. Z. Perceptions of Human Tuberculosis Vaccine: The Fiocruz Latest Contribution. J. J. Vaccine Vaccination. v. 1, n. 1, p. 1-2, 2014.
Copyright: open access
Appears in Collections:IOC - Artigos de Periódicos

Files in This Item:
File Description SizeFormat 
paulo_antas2_IOC_2014.pdf201.68 kBAdobe PDFView/Open


FacebookTwitterDeliciousLinkedInGoogle BookmarksBibTex Format mendeley Endnote DiggMySpace

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.